CK2-NCoR signaling cascade promotes prostate tumorigenesis

Jung-Yoon Yoo; Beom Jin Lim; Hyo-Kyoung Choi; Soon Won Hong; Ho Sung Jang; Changsoo Kim; Kyung-Hee Chun; Kyung-Chul Choi; HoGeun Yoon

doi:10.18632/oncotarget.1020

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

CK2-NCoR signaling cascade promotes prostate tumorigenesis

Jung-Yoon Yoo, Beom Jin Lim, Hyo-Kyoung Choi, Soon Won Hong, Ho Sung Jang, Changsoo Kim, Kyung-Hee Chun, Kyung-Chul Choi and HoGeun Yoon _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2013; 4:972-983. https://doi.org/10.18632/oncotarget.1020

Metrics: PDF 2988 views | HTML 4071 views | ?

Abstract

Jung-Yoon Yoo1,*, Beom Jin Lim2,*, Hyo-Kyoung Choi1, Soon Won Hong2, Ho Sung Jang3, Changsoo Kim4, Kyung-Hee Chun1,5, Kyung-Chul Choi6, and Ho-Geun Yoon1

1 Department of Biochemistry and Molecular Biology, Brain Korea 21 Project for Medical Sciences, Yonsei University College of Medicine, Seoul 120-752, Korea

2 Department of Pathology, Yonsei University College of Medicine, Seoul 120-752, Korea

3 Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea

4 Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea

5 Genitourinary Cancer Branch, Division of Translational and Clinical Research II, National Cancer Center Research Institute and Hospital, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea

6 Asan Medical Center, University of Ulsan College of Medicine, 388-1 Poongnap-DONG, Songpa-gu, Seoul 138-736, Korea

* Contributed equally to the work

Correspondence:

Kyung-Chul Choi, email:

Ho-Geun Yoon, email:

Keywords: CK2α, NCoR, Prostate cancer, IP-10, transcriptional regulation

Received: May 7, 2013, Accepted: May 10, 2013, Published: May 11, 2013

Abstract

The aberrant expressions of casein kinase 2 (CK2) was found in prostate cancer patient and cell lines, but little is known of the detailed mechanisms implicated in prostate tumorigenesis. In this study, we report that both CK2 activity and CK2-mediated NCoR phosphorylation are significantly elevated in the androgen-independent prostate cancer cell line DU145 and PC-3 compared with RWPE1 and LNCaP cells. Increased phosphorylation inversely correlates with the mRNA level of the NCoR-regulated gene, interferon-γ-inducible protein 10 (IP-10). CK2 inhibition abrogated NCoR phosphorylation, IP-10 transcriptional repression, and the invasion activity of PC-3 cells. Inhibition of the CK2-NCoR network significantly reduced in vivo PC-3 cell tumorigenicity, likely due to transcriptional derepression of IP-10. Clinicopathological analyses revealed that increased CK2-mediated NCoR phosphorylation significantly correlates with poor survival among prostate cancer patients. These findings elucidate a CK2-modulated oncogenic cascade in prostate tumorigenesis.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 1020

Publication Alerts

Research Papers:

CK2-NCoR signaling cascade promotes prostate tumorigenesis

Abstract